QDEL Share Price

Open 41.08 Change Price %
High 41.58 1 Day -0.11 -0.27
Low 40.93 1 Week 0.00 0.00
Close 40.95 1 Month -1.91 -4.46
Volume 309086 1 Year 18.96 86.22
52 Week High 45.55
52 Week Low 18.25
QDEL Important Levels
Resistance 2 41.55
Resistance 1 41.30
Pivot 41.15
Support 1 40.60
Support 2 40.35
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
MU 44.31 6.39%
MU 44.31 6.39%
MU 44.31 6.39%
RIMM 13.03 0.39%
More..
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
SCHS 0.04 33.33%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
HLIT 3.70 25.42%
OTT 2.39 25.13%
QNST 8.90 20.76%
VRTA 4.00 19.40%
SNSS 2.56 19.07%
GCFB 0.44 18.92%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
GMETP 0.15 -76.92%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
More..

Quidel Corporation (NASDAQ: QDEL)

QDEL Technical Analysis 4
As on 31st Oct 2017 QDEL Share Price closed @ 40.95 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 27.77 & Buy for SHORT-TERM with Stoploss of 39.30 we also expect STOCK to react on Following IMPORTANT LEVELS.
QDEL Target for November
1st Target up-side 44.29
2nd Target up-side 46.63
3rd Target up-side 48.97
1st Target down-side 37.61
2nd Target down-side 35.27
3rd Target down-side 32.93
QDEL Other Details
Segment EQ
Market Capital 592634944.00
Sector Healthcare
Industry Diagnostic Substances
Offical website http://www.quidel.com
QDEL Address
QDEL
10165 McKellar Court
San Diego, CA 92121
United States
Phone: 858-552-1100
Fax: 858-453-4338
QDEL Latest News
Interactive Technical Analysis Chart Quidel Corporation ( QDEL NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Quidel Corporation
QDEL Business Profile
Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions primarily include applications in infectious diseases, women�s health and gastrointestinal diseases. It sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics and wellness screening centers. It markets its products in the United States through a network of national and regional distributors, and a direct sales force. Internationally, it sells and markets primarily in Japan and Europe through distributor arrangements. It provides diagnostic testing solutions under various brand names, including QuickVue, QuickVue+, Quidel, MicroVueTM, FreshCells , D3 FastPoint, Super E-Mix, ELVIS, Sofia , Quidel Molecular, and Thyretain. In May 2013, the Company completed the acquisition of BioHelix Corporation.